DAVENPORT & Co LLC Invests $334,000 in Calumet, Inc. $CLMT

DAVENPORT & Co LLC bought a new stake in shares of Calumet, Inc. (NASDAQ:CLMT) during the 4th quarter, according to its most recent filing with the SEC. The fund bought 16,800 shares of the oil and gas company’s stock, valued at approximately $334,000.

Several other hedge funds have also recently added to or reduced their stakes in CLMT. Two Seas Capital LP boosted its holdings in Calumet by 56.9% during the second quarter. Two Seas Capital LP now owns 4,497,609 shares of the oil and gas company’s stock valued at $70,860,000 after purchasing an additional 1,631,098 shares in the last quarter. AYAL Capital Advisors Ltd bought a new position in shares of Calumet during the 2nd quarter worth approximately $5,278,000. Mariner LLC lifted its position in shares of Calumet by 959.6% during the 3rd quarter. Mariner LLC now owns 369,408 shares of the oil and gas company’s stock worth $6,742,000 after buying an additional 334,544 shares during the period. Marshall Wace LLP boosted its stake in Calumet by 35.8% in the 3rd quarter. Marshall Wace LLP now owns 891,390 shares of the oil and gas company’s stock valued at $16,268,000 after buying an additional 234,766 shares in the last quarter. Finally, BNP Paribas Financial Markets boosted its stake in Calumet by 18,512.3% in the 2nd quarter. BNP Paribas Financial Markets now owns 183,890 shares of the oil and gas company’s stock valued at $2,897,000 after buying an additional 182,902 shares in the last quarter. Institutional investors and hedge funds own 34.41% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have issued reports on CLMT shares. Weiss Ratings reiterated a “sell (d-)” rating on shares of Calumet in a research note on Monday, December 29th. TD Cowen boosted their target price on shares of Calumet from $19.00 to $25.00 and gave the company a “hold” rating in a research note on Thursday, March 5th. UBS Group reaffirmed a “neutral” rating and issued a $26.00 target price on shares of Calumet in a report on Friday, February 13th. Wall Street Zen cut shares of Calumet from a “buy” rating to a “hold” rating in a research report on Sunday, December 14th. Finally, The Goldman Sachs Group boosted their price target on shares of Calumet from $24.00 to $34.00 and gave the company a “buy” rating in a research report on Thursday, March 12th. Four equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Calumet has a consensus rating of “Hold” and a consensus price target of $30.17.

Calumet Stock Performance

Shares of CLMT stock opened at $34.59 on Thursday. Calumet, Inc. has a 52 week low of $7.68 and a 52 week high of $36.94. The stock has a market capitalization of $3.00 billion, a PE ratio of -88.69 and a beta of 0.85. The stock’s fifty day moving average is $27.64 and its 200-day moving average is $22.21.

Calumet (NASDAQ:CLMT) last issued its quarterly earnings results on Friday, February 27th. The oil and gas company reported ($0.43) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.67) by $0.24. The company had revenue of $1.04 billion during the quarter, compared to analyst estimates of $1.04 billion. During the same period in the prior year, the business earned ($0.47) EPS. The business’s revenue for the quarter was up 9.4% on a year-over-year basis. As a group, analysts forecast that Calumet, Inc. will post -3.02 earnings per share for the current fiscal year.

Key Calumet News

Here are the key news stories impacting Calumet this week:

• Positive Sentiment: HC Wainwright raised Q1–Q4 2026 and FY2026 EPS estimates and boosted FY2027 to $1.07, while keeping a Buy rating and $60 target — this is the core bullish catalyst for the recent rally. Calumet (NASDAQ:CLMT) Stock Price Expected to Rise, HC Wainwright Analyst Says
• Positive Sentiment: Analyst-driven optimism produced a volume‑backed move (Zacks notes a ~12% intraday surge), suggesting momentum and renewed investor interest after the estimate upgrades. Calumet, Inc. (CLMT) Soars 12%: Is Further Upside Left in the Stock?
• Neutral Sentiment: Coverage and commentary are prompting re‑rating conversations; Yahoo Finance looks at valuation after the recent run, which could temper enthusiasm if multiples appear stretched versus fundamentals. A Look At Calumet (CLMT) Valuation After Its Recent Share Price Surge
• Negative Sentiment: Despite upgrades, consensus full‑year estimates remain negative (noted around ($3.02) previously) and the company has a history of volatile quarterly results — fundamentals still need to improve to justify a $60 target, leaving downside risk if momentum fades. MarketBeat CLMT Overview

About Calumet

Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is an independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks. The company operates an integrated network of manufacturing plants, blending terminals and storage facilities across North America, delivering customized products and technical services to industrial, automotive, consumer and agricultural end markets. By leveraging its scale and technical expertise, Calumet tailors supply chain and formulation solutions to meet stringent regulatory and performance requirements.

Calumet’s product portfolio includes specialty lubricants and base oils for high-performance applications; process oils and waxes for food-grade, cosmetic and packaging uses; industrial solvents and cleaning solutions; and fuel additives designed to optimize engine performance and emissions.